CONDENSED CONSOLIDATED STATEMENTS OF MEZZANINE EQUITY AND STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Series X Non Voting Convertible Preferred Stock	Common Stock	Additional Paid-in Capital.	Accumulated Other Comprehensive Income	Accumulated Deficit	Total
Balance at the beginning of the period (in shares) at Dec. 31, 2022		9,902,137
Balance at the beginning of the period at Dec. 31, 2022		$ 10	$ 376,896	$ 128	$ (318,168)	$ 58,866
Increase (Decrease) in Stockholders' Equity
Issuance of Series X Preferred Stock in connection with Flame merger	$ 67,715
Issuance of Series X Preferred Stock in connection with Flame merger (in shares)	136,248
Issuance of common stock in connection with Flame merger		$ 2	9,803			9,805
Issuance of common stock in connection with Flame merger (in shares)		1,972,901
Issuance of common stock warrants in connection with Flame merger			13			13
Redemption of 2019 Warrants			(29)			(29)
Issuance of common stock upon vest of restricted stock units (in shares)		66,061
Conversion of Series X preferred stock to common stock	$ (67,715)	$ 14	67,701			67,715
Conversion of Series X preferred stock to common stock (in shares)	(136,248)
Conversion of Series X preferred stock to common stock (in shares)		13,624,800
Reclassification of Series X preferred stock warrants to equity			78			78
Fractional shares paid in cash			2			2
Fractional shares paid in cash (in shares)		(485)
Foreign currency translation adjustment				632		632
Stock-based compensation			3,875			3,875
Net loss					(68,949)	(68,949)
Balance at the end of the period at Sep. 30, 2023		$ 26	458,339	760	(387,117)	72,008
Balance at the end of the period (in shares) at Sep. 30, 2023		25,565,414
Balance at the beginning of the period (in shares) at Jun. 30, 2023		25,565,414
Balance at the beginning of the period at Jun. 30, 2023		$ 26	457,038	414	(373,421)	84,057
Increase (Decrease) in Stockholders' Equity
Fractional shares paid in cash			1			1
Foreign currency translation adjustment				346		346
Stock-based compensation			1,300			1,300
Net loss					(13,696)	(13,696)
Balance at the end of the period at Sep. 30, 2023		$ 26	458,339	760	(387,117)	72,008
Balance at the end of the period (in shares) at Sep. 30, 2023		25,565,414
Balance at the beginning of the period (in shares) at Dec. 31, 2023		25,565,414
Balance at the beginning of the period at Dec. 31, 2023		$ 26	459,591	106	(399,582)	60,141
Increase (Decrease) in Stockholders' Equity
Issuance of common stock upon vest of restricted stock units (in shares)		27,500
Issuance of common stock upon exercise of stock options			29			$ 29
Issuance of common stock upon exercise of stock options (in shares)		10,557				10,557
April 2024 Private Placement (net of issuance costs of $2,948)		$ 12	37,039			$ 37,051
April 2024 Private Placement (net of issuance costs of $2,948) (in shares)		12,660,993
Dividend attributable to the down round feature of 2017 Warrants			234		(234)
Foreign currency translation adjustment				(100)		(100)
Stock-based compensation			3,957			3,957
Net loss					(52,124)	(52,124)
Balance at the end of the period at Sep. 30, 2024		$ 38	500,850	6	(451,940)	48,954
Balance at the end of the period (in shares) at Sep. 30, 2024		38,264,464
Balance at the beginning of the period (in shares) at Jun. 30, 2024		38,264,464
Balance at the beginning of the period at Jun. 30, 2024		$ 38	499,511	3	(433,764)	65,788
Increase (Decrease) in Stockholders' Equity
Foreign currency translation adjustment				3		3
Stock-based compensation			1,339			1,339
Net loss					(18,176)	(18,176)
Balance at the end of the period at Sep. 30, 2024		$ 38	$ 500,850	$ 6	$ (451,940)	$ 48,954
Balance at the end of the period (in shares) at Sep. 30, 2024		38,264,464